Private equity target imo. Cheap interest rates will provide the capital needed for a takeover. Doesn't help those who paid much higher as any offer will be a low ball price.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
